![SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT](https://minio.scielo.br/documentstore/1677-6119/qpZZZW5nFmHVkyXd6K7hctp/b3e13c0edc362abe0f6389f8ff2227391155302b.jpg)
SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT
![68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports 68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-24688-3/MediaObjects/41598_2022_24688_Fig1_HTML.jpg)
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports
![Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - ScienceDirect Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879850017302060-gr1.jpg)
Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease - ScienceDirect
![An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/61/2/202/F3.large.jpg)
An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine
![68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram 68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram](https://www.researchgate.net/publication/322258012/figure/fig2/AS:611053327118336@1522697874735/68-Ga-PSMA-PET-CT-identified-solitary-L5-metastasis-in-patient-with-recurrent-prostate.png)
68 Ga-PSMA PET/CT identified solitary L5 metastasis in patient with... | Download Scientific Diagram
![NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA](https://www.iaea.org/sites/default/files/crp-prostate1140x640.jpg)
NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA
![Frontiers | Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer Frontiers | Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer](https://www.frontiersin.org/files/Articles/585213/fonc-10-585213-HTML-r1/image_m/fonc-10-585213-g001.jpg)
Frontiers | Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
![Latest Prostate Cancer Imaging Technique Transforms Our Ability to Locate Cancer Cells Hidden with Standard Imaging Latest Prostate Cancer Imaging Technique Transforms Our Ability to Locate Cancer Cells Hidden with Standard Imaging](https://news.cuanschutz.edu/hubfs/Cancer%20Center/PSMA-PET-Hubspot%20Newsroom%20Header.png)
Latest Prostate Cancer Imaging Technique Transforms Our Ability to Locate Cancer Cells Hidden with Standard Imaging
![FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News](http://www.itnonline.com/sites/default/files/PSMA_PET.jpg)
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News
![Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study | BMC Cancer | Full Text Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07192-7/MediaObjects/12885_2020_7192_Fig2_HTML.png)
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study | BMC Cancer | Full Text
![Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer | Scientific Reports Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59296-6/MediaObjects/41598_2020_59296_Fig1_HTML.png)